News

Unnatural selection

Hospital-acquired fungal infections, which pose a serious risk to immunocompromised patients, are a growing global health challenge. In a new study…

Read more

DOC Fellowships awarded to numerous Vienna BioCenter Phd Students

The Austrian Academy of Sciences (ÖAW)’s DOC Fellowship program supports outstanding PhD students by funding their innovative research projects. This…

Read more

A new start for mitophagy

The recycling of damaged or surplus organelles by autophagy is crucial to maintaining cellular fitness. Dysregulation of mitophagy, in particular, is…

Read more

Eveliqure Announces Dosing of First Participants in a Phase 2b study of the ShigETEC Vaccine in Shigellosis

Eveliqure Biotechnologies GmbH, a biotech company developing vaccines for the prevention of diarrhoeal diseases announced today that the first…

Read more

Making diagnostics simpler, cheaper and open-source

Access to reliable molecular diagnostics in low- and middle-income countries is often limited by high costs and complicated logistics. In the current…

Read more

Two new EMBO Fellows on Campus

Guilherme Bastos-Ventura (Postdoc at the Research Institute of Molecular Pathology) and Hyosang Kim (Postdoc at the Institute of Molecular…

Read more

Two Advanced ERC Grants awarded to Vienna BioCenter Researchers

Dagmar Wöbken (CeMESS) and Alwin Köhler (Max Perutz Labs) have been awarded with the highly competitive European Research Council (ERC) Advanced…

Read more

HeartBeat.bio and biotx.ai Sign License and Technology Access Agreement to Identify Novel Targets in Heart Failure

HeartBeat.bio AG and biotx.ai GmbH today announced a strategic partnership to identify and validate novel therapeutic targets in heart failure. The…

Read more

Celebrating 20 years of transformative basic research at the Perutz

The Max Perutz Labs celebrated their 20th anniversary on June 24 with a special event honoring two decades of pioneering research in molecular…

Read more

Cut to fit

Precise regulation of the innate immune response is critical in the fight against pathogens. A new study by Adrian Söderholm (Versteeg lab), published…

Read more

Clemens Plaschka elected EMBO member

Clemens Plaschka, Senior Group Leader at the IMP, has been elected to the prestigious European Molecular Biology Organization (EMBO), becoming the…

Read more

How do human antibodies get better at fighting infections?

A team of researchers from the Pavri lab at the IMP have discovered how B cells organize the genes and regulatory regions involved in somatic…

Read more